Caremo Gains CNAS Accreditation, Securing National Recognition for Testing Competence

Recently, the bioanalytical laboratory of Caremo has obtained accreditation from the China National Accreditation Service for Conformity Assessment (CNAS), marking the company’s alignment with international standards in both technical capabilities and management systems within the bioanalysis field. This achievement represents another critical milestone in Caremo’s strategic progression toward building an internationally competitive innovation platform for pharmaceutical services.

CNAS Accreditation: A Globally Recognized "Passport of Competence"

CNAS accreditation stands as the highest national benchmark for laboratory competence in China, certifying compliance with the ISO/IEC 17025 international standard. Laboratories accredited by CNAS are recognized as authoritative and credible testing institutions, with their data and reports mutually accepted by over 100 global regulatory authorities.

Empowering Pharmaceutical Innovation Through Rigorous Standards

Since its inception, Caremo’s bioanalytical laboratory has rigorously adhered to CNAS requirements, systematically establishing a comprehensive management system encompassing quality control, technical operations, and support services. During the accreditation review, CNAS experts conducted meticulous evaluations of documentation, personnel competency, equipment and facilities, testing protocols, and data integrity. Following a holistic assessment, the laboratory was confirmed to fully meet CNAS accreditation criteria.

CNAS accreditation is not merely a credential but a testament to Caremo’s dedication to quality. This achievement will further strengthen the company’s service advantages in the pharmaceutical CRO (Contract Research Organization) sector.

Building on this international recognition, Caremo will continue enhancing its quality management systems while delivering high-efficiency, precision-driven technical services. The company remains committed to collaborating with global biotech and pharmaceutical partners across the entire R&D value chain—from target validation to commercialization. By addressing diverse client needs and offering flexible collaboration models, Caremo provides a fully integrated, end-to-end platform for drug discovery and manufacturing, delivering comprehensive technical and industrial support to advance global biopharmaceutical innovation.